Filing Flows › Sensus Healthcare (SRTS) › Q4 2025
Sensus Healthcare (SRTS) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 4, 2026
Sensus Healthcare (SRTS) reported revenue of $4.9M for the fourth quarter 2025 (Q4 2025), -62% from a year earlier and -28% from the quarter before. Operating margin was -63.7%, net loss $3.2M (64.1% of revenue).
Sensus Healthcare, Q4 2025: revenue $4.9M (-62% year over year), operating margin -63.7%, net loss $3.2M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.9M | -28% | -62% |
| Operating profit | −$3.1M | — | -282% |
| Net earnings | −$3.2M | — | -305% |
| Operating cash flow | −$2.2M | -196% | — |
What changed
Revenue was $4.9M in Q4 2025, down 62% year over year and down 28% from the previous quarter. Product was the largest line at 57% of revenue.
Gross margin was 38.4%, down 16.0 points from Q4 2024. Operating costs exceeded revenue by $3.1M, an operating margin of -63.7%. Operating expenses fell 6% while revenue fell 62%. The fastest-growing cost line was Research & development (+21%). The quarter ended with a net loss of $3.2M, wider than the previous quarter's $943K loss.
Operating cash flow was −$2.2M. Non-cash charges added back $103K of depreciation and $76K of share-based compensation. Working capital and other items added $781K. Capital expenditures of $158K exceeded it, leaving free cash flow of −$2.4M.
Questions
What was Sensus Healthcare's revenue in the fourth quarter 2025?
Sensus Healthcare (SRTS) reported revenue of $4.9M for the fourth quarter 2025 (Q4 2025), -62% from a year earlier and -28% from the quarter before.
Was Sensus Healthcare profitable in the fourth quarter 2025?
Operating loss was $3.1M (-63.7% of revenue) and net loss $3.2M.
Source: Sensus Healthcare 10-K on SEC EDGAR.